Claire Mazumdar, Chief Executive Officer at Bicara Therapeutics Inc. (BCAX), sold 16,468 shares at $18.73 ($309K) on 2026-03-04, disclosed to the SEC on 2026-03-06.
Open-market sale of $309k BCAX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.73 | 2,631 | $49K | 16.0% |
| 2 | $18.73 | 2,631 | $49K | 16.0% |
| 3 | $18.74 | 1,786 | $33K | 10.8% |
| 4 | $18.74 | 1,786 | $33K | 10.8% |
| 5 | $18.75 | 3,817 | $72K | 23.2% |
| 6 | $18.75 | 3,817 |
| $72K |
| 23.2% |
| Total | $18.74 avg | 16,468 | $309K | 100% |
| Filing → |
| BCAX | SELL | 2026-05-20 | $301K | — | Filing → |
| BCAX | SELL | 2026-04-20 | $354K | — | Filing → |
| BCAX | SELL | 2026-03-20 | $565K | — | Filing → |